Literature DB >> 8183226

Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention.

.   

Abstract

Although previous recommendations for preventing transmission of human immunodeficiency virus (HIV) through transplantation of human tissue and organs have markedly reduced the risk for this type of transmission, a case of HIV transmission from a screened, antibody-negative donor to several recipients raised questions about the need for additional federal oversight of transplantation of organs and tissues. A working group formed by the Public Health Service (PHS) in 1991 to address these issues concluded that further recommendations should be made to reduce the already low risk of HIV transmission by transplantation of organs and tissues. In revising these recommendations, the PHS sought assistance from public and private health professionals and representatives of transplant, public health, and other organizations. The revised guidelines address issues such as donor screening, testing, and exclusionary criteria; quarantine of tissue from living donors; inactivation or elimination of infectious organisms in organs and tissues before transplantation; timely detection, reporting, and tracking of potentially infected tissues, organs, and recipients; and recall of stored tissues from donors found after donation to have been infected. Factors considered in the development of these guidelines include differences between the screening of living and cadaveric donors; time constraints due to organ/tissue viability that may preclude performing certain screening procedures; differences in the risk of HIV transmission from various organs and tissues; differences between systems for procuring and distributing organs and tissues; the effect of screening practices on the limited availability of organs and some tissues; and the benefit of the transplant to the recipient.

Entities:  

Mesh:

Year:  1994        PMID: 8183226

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  35 in total

Review 1.  Development of organ-specific donor risk indices.

Authors:  Sanjeev K Akkina; Sumeet K Asrani; Yi Peng; Peter Stock; W Ray Kim; Ajay K Israni
Journal:  Liver Transpl       Date:  2012-04       Impact factor: 5.799

2.  Perspectives on creating a balanced approach to organ transplantation safety and availability.

Authors:  Howard K Koh
Journal:  Public Health Rep       Date:  2013-07       Impact factor: 2.792

3.  PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.

Authors:  Debbie L Seem; Ingi Lee; Craig A Umscheid; Matthew J Kuehnert
Journal:  Public Health Rep       Date:  2013-07       Impact factor: 2.792

Review 4.  What's new in clinical solid organ transplantation by 2013.

Authors:  Maurizio Salvadori; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2014-12-24

Review 5.  Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis.

Authors:  L M Kucirka; H Sarathy; P Govindan; J H Wolf; T A Ellison; L J Hart; R A Montgomery; R L Ros; D L Segev
Journal:  Am J Transplant       Date:  2011-03-02       Impact factor: 8.086

6.  Risk factors for multidrug-resistant organisms among deceased organ donors.

Authors:  Judith A Anesi; Emily A Blumberg; Jennifer H Han; Dong H Lee; Heather Clauss; Antonette Climaco; Richard Hasz; Esther Molnar; Darcy Alimenti; Sharon West; Warren B Bilker; Pam Tolomeo; Ebbing Lautenbach
Journal:  Am J Transplant       Date:  2019-06-26       Impact factor: 8.086

7.  Geographic determinants of access to pediatric deceased donor kidney transplantation.

Authors:  Peter P Reese; Hojun Hwang; Vishnu Potluri; Peter L Abt; Justine Shults; Sandra Amaral
Journal:  J Am Soc Nephrol       Date:  2014-01-16       Impact factor: 10.121

8.  Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.

Authors:  Mary G Bowring; Courtenay M Holscher; Sheng Zhou; Allan B Massie; Jacqueline Garonzik-Wang; Lauren M Kucirka; Sommer E Gentry; Dorry L Segev
Journal:  Am J Transplant       Date:  2017-12-05       Impact factor: 8.086

9.  Donor-derived infection: epidemiology and outcomes.

Authors:  Daniel R Kaul
Journal:  Curr Infect Dis Rep       Date:  2012-12       Impact factor: 3.725

10.  Transplantation of kidneys from donors at increased risk for blood-borne viral infection: recipient outcomes and patterns of organ use.

Authors:  P P Reese; H I Feldman; D A Asch; S D Halpern; E A Blumberg; A Thomasson; J Shults; R D Bloom
Journal:  Am J Transplant       Date:  2009-08-21       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.